Certara Inc (CERT) Stock Analysis

Certara Inc (CERT) is a publicly traded company in the HEALTHCARE sector. It trades at $5.62, carries a market capitalization of $905.39M. This page summarizes the public market data, fundamentals, and frequently asked questions for CERT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

• Price: $5.62
• Market Cap: $905.39M
• EPS: $-0.10
• 52-Week High: $13.88
• 52-Week Low: $4.45

Market Sentiment

Certara Inc currently has a Bearish sentiment score of -0.30.

About Certara Inc

Certara Inc. (CERT) is a prominent provider of biosimulation software and technology services designed to enhance the efficiency of drug discovery, preclinical and clinical research, and regulatory compliance. Headquartered in Princeton, New Jersey, the company utilizes advanced modeling and simulation techniques to empower pharmaceutical companies in making data-driven decisions that facilitate faster market access for new therapies. With a steadfast commitment to innovation, Certara is dedi...

GNG Research Analysis

GNG Research scores Certara Inc (CERT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CERT.

Frequently Asked Questions

Does CERT pay dividends?

Certara Inc (CERT) does not currently pay a regular dividend.

What is CERT's market cap?

Certara Inc (CERT) has a market capitalization of $905.39M with a current stock price of $5.62.